Introduction: Bacterial infections that cause community-acquired urinary tract infections
INTRODUCTION
Antimicrobial pressure, prescribing practices, and cultural factors, such as drug availability and cost, produce significant regional susceptibility differences among certain bacterial pathogens [1] [2] [3] [4] [5] [6] . Individual countries first-line treatment options differ and may not be appropriate due to variable resistance patterns in local environments [2] .
Country-specific surveillance data are available in most regions, but can be confounding based on the variation of results obtained from different investigations and differences in the susceptibility breakpoints applied in these studies.
Regardless, surveillance studies provide useful information to primary care physicians who need to prescribe rational empiric therapy.
Community-acquired urinary tract infections (CA-UTI) and upper respiratory tract infections (CA-URTI) are the leading causes of outpatient infections and the most empirically treated infections worldwide [1, 6, 7] . Increased resistance to antibiotics has complicated the management of both of these outpatient infections. The spread of Enterobacteriaceae that carry a chromosomally mediated AmpC b-lactamase, an extended-spectrum b-lactamase (ESBL), or a carbapenemase is becoming a significant concern in the community [8] [9] [10] [11] .
Multidrug-resistant
Streptococcus pneumoniae and b-hemolytic streptococci with tolerance to penicillin and resistance to macrolides and fluoroquinolones are increasing in Japan and extreme drug-resistant S. pneumoniae have been observed among multidrug-resistant isolates in Canada [12, 13] .
Regional and country variations in pathogen resistance and the susceptibility breakpoint differences that are applied must be considered when determining empiric treatment options for both CA-UTI and CA-URTI [14, 15] . Many countries' adopt or design their own recommendations of treatment guidelines based on local surveillance data which can be scarce in some countries [1] [2] [3] [4] [5] [6] . (Russia) using CLSI breakpoint criteria. All Enterobacteriaceae isolated from CA-URTI were susceptible to fluoroquinolones using CLSI but \80% using EUCAST breakpoints while susceptibility percentages ranged from 64% to 79% for the other agents tested using either CLSI or EUCAST breakpoints (data on file, IHMA Inc. 
DISCUSSION
This study determined the activity of oral antimicrobial agents from countries with limited information on the susceptibility patterns for pathogens which cause CA-UTI and CA-URTI. Oral cephalosporins tested in this study had activity against the majority of on the source of the infection and the pharmacokinetic and pharmacodynamics of the drug class, the loss of activity among other commonly used oral agents warrants the need to continue to monitor the viability of oral cephalosporins and other drugs used for treating outpatient infections.
It is important that local epidemiology efforts continue to determine the rate of emerging or epidemic clones and the resistance rates among several class agents which vary based on the susceptibility breakpoints applied [19] [20] [21] . It is equally important to follow the variation of prescribing practices and to reduce antibiotic consumption in the ambulatory setting as this affects antimicrobial resistance in the hospital setting [22, 23] . 
CONCLUSION

